top of page
BIOTECHNOLOGY RESEARCH FOR NERVOUS SYSTEM DISORDERS

Huxley Health is a Global Biotechnology Enterprise, Harnessing the Power of Psychedelics to Develop Groundbreaking Therapies for Neuroinflammatory and Neuropsychiatric Disorders.

​

Founded by a Team of Accomplished Entrepreneurs, Scientists, and Academics, Huxley adopts a Targeted, Capital-Efficient, Research Intensive Approach.

 

In partnership with world leading institutions, Huxley is redefining R&D in the biotechnology and drug discovery sector, leading the way with innovative approaches.

image_edited_edited_edited_edited_edited

10+

U.S. FILED PATENTS

IP Portfolio Protecting
Novel Compounds and Formulations. 

30+

 BILLION COMPOUNDS SCREENED

 Leading AI-Enhanced Drug Development 

4

FEDERAL RESEARCH GRANTS RECEIVED

Maximizing R&D While Reducing Traditional Costs.

ABOUT

OUR APPROACH TO R&D

Artboard 1.png
INNOVATIVE  R&D

Transforming Biotech via cutting-edge AI technology driving innovation in development.

DIVERSE EXPERTISE & LEADERSHIP

Huxley is a team of biotech experts, entrepreneurs, and partners from world-leading institutions, coming together to create a unique and groundbreaking approach to drug development.

FFF.png
DIVERSE IP PORTFOLIO

A robust portfolio of  I.P. crafted by top-tier scientists and biotech innovators. Our IP showcases cutting-edge advancements in redefining Psychedelic research, offering unique investment opportunities.

SERVICES
CLIENTS
Laboratory

STRATEGIC PARTNERSHIPS

image.png
image.png
image.png
image.png
bottom of page